{"id":"W4385827492","doi":"10.1111/dom.15234","title":"Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Professional Engineers Ontario; Western University; Ottawa Hospital; University of Ottawa; Hamilton Health Sciences; McGill University; University of Calgary; Impact; LMC Diabetes & Endocrinology (Canada); McMaster University; Population Health Research Institute","funders":"Obesity Canada; Canadian Institutes of Health Research; Bayer Canada; National Institutes of Health; HLS Therapeutics; Bausch Health; Mitacs; Novo Nordisk; Dexcom; Insulet Corporation; Diabetes Canada; University of Calgary; Kowa Company; Sanofi; Hamilton Health Sciences; GlaxoSmithKline; McMaster University; Lawson Foundation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Alberta Health Services; Pfizer","keywords":"Medicine; Metformin; Diabetes mellitus; Type 2 diabetes; Insulin glargine; Internal medicine; Hazard ratio; Lixisenatide; Confidence interval; Insulin; Endocrinology; Liraglutide","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003519409,0.001491801,0.004335623,0.0005326229,0.0004367984,0.000941315,0.0009568234,0.002322684,0.006543532],"category_scores_gemma":[0.004278985,0.0007701548,0.004812851,0.0006643162,0.001313569,0.0008747398,0.0007093006,0.002471466,0.000607268],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007954854,"about_ca_system_score_gemma":0.001217812,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001721966,"about_ca_topic_score_gemma":0.001990766,"domain_scores_codex":[0.9970167,0.001860241,0.0003202356,0.0003515967,0.0001982755,0.0002530522],"domain_scores_gemma":[0.9970359,0.001331102,0.0006419736,0.0002436738,0.0001301524,0.0006172387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9861893,0.003811924,0.0003750327,0.0007435476,0.001342856,0.00001629117,0.00002714481,0.00009925485,0.0003636907,0.00002534376,0.0001164815,0.006889163],"study_design_scores_gemma":[0.9572411,0.03942544,0.001709676,0.00006841835,0.001052836,0.0000146202,0.00001294445,0.0001761035,0.0001129408,0.00005291612,0.0001235637,0.000009477399],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986931,0.007182307,0.0005873177,0.0005390024,0.000624664,0.002567002,0.0004514155,0.00008365818,0.001033657],"genre_scores_gemma":[0.9866851,0.004044592,0.001429621,0.0006826655,0.0007517468,0.004381947,0.0005264365,0.00001766478,0.001480279],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006543532,"threshold_uncertainty_score":0.02189034,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02201778733957899,"score_gpt":0.2561282778115219,"score_spread":0.2341104904719429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}